EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study

Lexy Sorrell iD, Valentina Leta, Anton Barnett iD, Kara Stevens, Angela King, Jemma Inches, Christopher Kobylecki iD, Richard Walker, K Ray Chaudhuri, Hannah Martin, Jane Rideout, J Robert Sneyd iD und 3 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0285349 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Lexy Sorrell und 14 weiteren Autor:innen. Beteiligte Einrichtung: University of Plymouth, Plymouth, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Parkinson Disease, Frailty, Parkinsonian Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Parkinson’s UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease has been identified as a risk factor for severe Coronavirus disease 2019 (COVID-19) outcomes. However, whether the significant high risk of death from COVID-19 in people with Parkinson’s disease is specific to the disease itself or driven by other concomitant and known risk factors such as comorbidities, age, and frailty remains unclear.

Objective

To investigate clinical profiles and outcomes of people with Parkinson’s disease and atypical parkinsonian syndromes who tested positive for COVID-19 in the hospital setting in a multicentre UK-based study.

Methods

A retrospective cohort study of Parkinson’s disease patients with a positive SARS-CoV-2 test admitted to hospital between February 2020 and July 2021. An online survey was used to collect data from clinical care records, recording patient, Parkinson’s disease and COVID-19 characteristics. Associations with time-to-mortality and severe outcomes were analysed using either the Cox proportional hazards model or logistic regression models, as appropriate.

Results

Data from 552 admissions were collected: 365 (66%) male; median (inter-quartile range) age 80 (74–85) years. The 34-day all-cause mortality rate was 38.4%; male sex, increased age and frailty, Parkinson’s dementia syndrome, requirement for respiratory support and no vaccination were associated with increased mortality risk. Community-acquired COVID-19 and co-morbid chronic neurological disorder were associated with increased odds of requiring respiratory support. Hospital-acquired COVID-19 and delirium were associated with requiring an increase in care level post-discharge.

Conclusions

This first, multicentre, UK-based study on people with Parkinson’s disease or atypical parkinsonian syndromes, hospitalised with COVID-19, adds and expands previous findings on clinical profiles and outcomes in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Parkinson DiseaseFrailtyParkinsonian DisordersHumansMaleAged, 80 and overFemaleSARS-CoV-2Retrospective StudiesAftercarePatient DischargeUnited Kingdom

Autor:innen und Institutionen

  • University of Plymouth, Plymouth, United Kingdom.
  • Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.
  • Parkinson's Foundation Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Exploristics Ltd, Belfast, Northern Ireland, United Kingdom.
  • University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Division of Neuroscience and Experimental Psychology, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.

ORCID-Profile: Lexy Sorrell, Anton Barnett, Christopher Kobylecki, J Robert Sneyd

Förderung

  • Parkinson’s UK

Zitieren

APA

Sorrell, L., Leta, V., Barnett, A., Stevens, K., King, A., Inches, J., Kobylecki, C., Walker, R., Chaudhuri, K. R., Martin, H., Rideout, J., Sneyd, J. R., Campbell, S., Carroll, C., & COVID-19 PD UK study team (2023). Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study. PLOS ONE. https://doi.org/10.1371/journal.pone.0285349

Vancouver

Sorrell L, Leta V, Barnett A, Stevens K, King A, Inches J, et al. Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study. PLOS ONE. 2023. doi:10.1371/journal.pone.0285349

BibTeX
@article{Sorrell2023,
  author = {Sorrell, Lexy and Leta, Valentina and Barnett, Anton and Stevens, Kara and King, Angela and Inches, Jemma and Kobylecki, Christopher and Walker, Richard and Chaudhuri, K Ray and Martin, Hannah and Rideout, Jane and Sneyd, J Robert and Campbell, Sarah and Carroll, Camille and COVID-19 PD UK study team, COVID-19 PD UK study team},
  title = {Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0285349}
}
Kostenlos starten →